-
Abstract Number: 659
Diminished Memory B-cells in Systemic Lupus Erythematosus Patients with Low Disease Activity
-
Abstract Number: 660
Antiphospholipid Syndrome (APS) in Systemic Lupus Erythematosus (SLE) Leads to a More Severe Disease
-
Abstract Number: 661
Association of Serum and Urine Levels of TWEAK, MCP-1 and NGAL with Disease Activity in Systemic Lupus Erythematosus
-
Abstract Number: 662
Utility of a Mobile Phone Based Application to Collect Patient-Reported Outcome Information from People Living with Systemic Lupus Erythematosus
-
Abstract Number: 663
Peripheral Blood Toll Like Receptor 7 Expression and Serum Interferon Lambda 1 Levels in Systemic Lupus Erythematosus and Their Relation to Disease Activity and Lupus Nephritis
-
Abstract Number: 664
Myxovirus Resistance Protein a Is a Useful Additional Histological Marker for Cutaneous Lupus Erythematosus
-
Abstract Number: 665
Utility of Repeat Renal Biopsies in Patients with Lupus Nephritis in Western Australia
-
Abstract Number: 666
Sensitivity to Change of the Patient Reported Outcomes Measurement Information System (PROMIS) Computerized Adaptive Test (CAT) Measures in a Single Canadian Lupus Cohort
-
Abstract Number: 667
The PROMIS-29 as a Measure of Type 1 and 2 SLE Activity
-
Abstract Number: 668
Lack of Uptake of Prophylactic Human Papilloma Virus (HPV) Vaccination Among Women with Systemic Lupus Erythematosus (SLE) in the Detroit, MI Area, a High Risk Population
-
Abstract Number: 669
Complement Activation in Probable Systemic Lupus Erythematosus (pSLE) May Predict Progression to SLE Defined by Fulfillment of ACR Classification Criteria
-
Abstract Number: 670
Association Between Ambient Air Pollutant Exposures and Childhood-Onset Systemic Lupus Erythematosus: A 12-Year Population-Based Cohort Study in Taiwan
-
Abstract Number: 671
Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
-
Abstract Number: 672
Mouse SLE Studies Do Not Describe Human SLE
-
Abstract Number: 673
Clinical Characteristics of Lymphadenopathy in Systemic Lupus Erythematous: A Case Control Study from a Tertiary Care Center
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 198
- Next Page »